Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25690401 | 0.80 | EGLN1 (0.48) | EGLN1 | |
| SCHEMBL25690381 | 0.80 | EGLN1 (0.48) | EGLN1 | |
| SCHEMBL23308729 | 0.76 | KDM4E (0.54) | EGLN1 | |
| SCHEMBL22326606 | 0.76 | KDM4E (0.54) | EGLN1 | |
| SCHEMBL30457318 | 0.69 | EGLN1 (0.67) | EGLN1EGLN2 | |
| SCHEMBL25227579 | 0.69 | EGLN1 (0.67) | EGLN1EGLN2 | |
| SCHEMBL10586417 | 0.65 | KDM4E (0.54) | — | |
| SCHEMBL30472839 | 0.64 | OPRK1 (0.43) | — | |
| SCHEMBL14319655 | 0.61 | EGLN1 (0.61) | EGLN1 | |
| SCHEMBL7095023 | 0.61 | CYP3A4 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023111990-A1 | SELECTIVE PHD1 INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | AKEBIA THERAPEUTICS, INC. (US) | 2023-06-22 | — | — | WO | disclosed |